Data gathered: December 11
Data Bits
Data Bits | Value / Change | Benchmark | |
---|---|---|---|
Job Posts | N/A | N/A | |
Sentiment | N/A | N/A | |
Webpage traffic | N/A | N/A | |
Employee Rating | N/A | N/A | |
Google Trends | N/A | N/A | |
Linkedin Employees | N/A | N/A | |
Patents | N/A | N/A | |
4chan Mentions | N/A | N/A | |
Facebook Engagement | N/A | N/A | |
Facebook followers | N/A | N/A | |
Stocktwits Mentions | N/A | N/A | |
Stocktwits Subscribers | N/A | N/A | |
Twitter Followers | N/A | N/A | |
Youtube Subscribers | N/A | N/A | |
Instagram Followers | N/A | N/A | |
News Mentions | N/A | N/A | |
Reddit Mentions | N/A | N/A | |
Business outlook | N/A | N/A |
In the news
Lions Gate shares rise on surprise profit, Plug Power stock plunges on supply warning and more moving stocksNovember 9 - DowJones |
|
![]() |
Jungheinrich Shares Slide on Weaker Forklift DemandNovember 9 - DowJones |
![]() |
Seeds of hope: China's hybrid rice yields fruitful crops in PakistanNovember 9 - DowJones |
Clean-Energy Stocks Have Collapsed. What Comes Next.November 9 - DowJones |
|
![]() |
EQRx, Inc.(NasdaqGM:EQRX) dropped from S&P Global BMI IndexNovember 8 - Marketscreener.com |
![]() |
EQRx, Inc.(NasdaqGM:EQRX) dropped from S&P Biotechnology Select Industry IndexNovember 8 - Marketscreener.com |
About EQRx
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States.

Price | $2.41 |
Target Price | Sign up |
Market Cap | $1.14B |
Dividend Yield | 0 |
Industry | Biotechnology |
Similar companies
Company | Price | AI Score |
---|
Financial performance View All
Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
---|---|---|---|---|---|
Q3 '23 | 0 | 82M | -82M | -83M | 13M |
Q2 '23 | 0 | 48M | -48M | -73M | -38M |
Q1 '23 | 0 | 31M | -31M | -83M | -98M |
Q4 '22 | 0 | 29M | -29M | -22M | -167M |
Q3 '22 | 0 | 34M | -34M | -85M | -90M |